Literature DB >> 16870467

Early cytokine responses after percutaneous magnetic resonance imaging guided laser thermoablation of malignant liver tumors.

Raija Kallio1, Roberto Sequeiros, Heljä-Marja Surcel, Pasi Ohtonen, Heikki Kiviniemi, Hannu Syrjälä.   

Abstract

An early systemic response induced by magnetic resonance imaging (MRI)-guided interstitial percutaneous laser thermoablation was analyzed in 13 consecutive patients with malignant liver tumors by serum interleukin (IL)-1beta, IL-6, IL-10, tumor necrosis factor (TNF)-alpha, its receptor TNFRI, and C-reactive protein (CRP) levels up to 72h after the procedures. Only IL-6 (p=0.033) and TNFRI (p<0.001) increased statistically significantly after ablation, while the TNF-alpha, IL-1 beta, and IL-10 levels remained unchanged. The peak median CRP response was 92mg/l. There was a dose-dependent correlation between the energy used and the maximum CRP values (tau=0.68, p=0.013). MRI-guided laser thermoablation induced an early systemic inflammatory reaction with statistically significantly elevated IL-6, TNFRI, and CRP levels but not TNF-alpha or IL-10 levels and without procedure-related complications, favoring this procedure as a safe therapeutic alternative for well-selected patients with liver tumors.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16870467     DOI: 10.1016/j.cyto.2006.06.003

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  6 in total

Review 1.  Postablation Immune Microenvironment: Synergy between Interventional Oncology and Immuno-oncology.

Authors:  DaeHee Kim; Joseph P Erinjeri
Journal:  Semin Intervent Radiol       Date:  2019-10-31       Impact factor: 1.513

2.  Serum inflammatory factors and circulating immunosuppressive cells are predictive markers for efficacy of radiofrequency ablation in non-small-cell lung cancer.

Authors:  T Schneider; A Sevko; C P Heussel; L Umansky; P Beckhove; H Dienemann; S Safi; J Utikal; H Hoffmann; V Umansky
Journal:  Clin Exp Immunol       Date:  2015-04-15       Impact factor: 4.330

3.  Comparative evaluation of percutaneous laser and radiofrequency ablation in patients with HCC smaller than 4 cm.

Authors:  Antonio Orlacchio; Francesca Bolacchi; Fabrizio Chegai; Alberto Bergamini; Elisa Costanzo; Costantino Del Giudice; Mario Angelico; Giovanni Simonetti
Journal:  Radiol Med       Date:  2013-11-26       Impact factor: 3.469

Review 4.  More than just tumor destruction: immunomodulation by thermal ablation of cancer.

Authors:  Sebastian P Haen; Philippe L Pereira; Helmut R Salih; Hans-Georg Rammensee; Cécile Gouttefangeas
Journal:  Clin Dev Immunol       Date:  2011-12-29

Review 5.  Immunological effect of local ablation combined with immunotherapy on solid malignancies.

Authors:  Yusuke Takahashi; Noriyuki Matsutani; Takashi Nakayama; Hitoshi Dejima; Hirofumi Uehara; Masafumi Kawamura
Journal:  Chin J Cancer       Date:  2017-06-07

6.  A Strategy for Precise Treatment of Cardiac Malignant Neoplasms.

Authors:  Wenshuo Wang; Jinqiang Shen; Hongyue Tao; Yun Zhao; Hui Nian; Lai Wei; Xiaoyuan Ling; Ye Yang; Limin Xia
Journal:  Sci Rep       Date:  2017-04-10       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.